175 related articles for article (PubMed ID: 38165377)
1. Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Cagol A; Benkert P; Melie-Garcia L; Schaedelin SA; Leber S; Tsagkas C; Barakovic M; Galbusera R; Lu PJ; Weigel M; Ruberte E; Radue EW; Yaldizli Ö; Oechtering J; Lorscheider J; D'Souza M; Fischer-Barnicol B; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Chan A; Salmen A; Pot C; Bridel C; Zecca C; Derfuss T; Lieb JM; Remonda L; Wagner F; Vargas MI; Du Pasquier RA; Lalive PH; Pravatà E; Weber J; Cattin PC; Absinta M; Gobbi C; Leppert D; Kappos L; Kuhle J; Granziera C
Neurology; 2024 Jan; 102(1):e207768. PubMed ID: 38165377
[TBL] [Abstract][Full Text] [Related]
2. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Cagol A; Schaedelin S; Barakovic M; Benkert P; Todea RA; Rahmanzadeh R; Galbusera R; Lu PJ; Weigel M; Melie-Garcia L; Ruberte E; Siebenborn N; Battaglini M; Radue EW; Yaldizli Ö; Oechtering J; Sinnecker T; Lorscheider J; Fischer-Barnicol B; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Chan A; Salmen A; Pot C; Bridel C; Zecca C; Derfuss T; Lieb JM; Remonda L; Wagner F; Vargas MI; Du Pasquier R; Lalive PH; Pravatà E; Weber J; Cattin PC; Gobbi C; Leppert D; Kappos L; Kuhle J; Granziera C
JAMA Neurol; 2022 Jul; 79(7):682-692. PubMed ID: 35575778
[TBL] [Abstract][Full Text] [Related]
3. Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials.
Ingwersen J; Masanneck L; Pawlitzki M; Samadzadeh S; Weise M; Aktas O; Meuth SG; Albrecht P
Sci Rep; 2023 Sep; 13(1):15003. PubMed ID: 37696848
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability.
Bussas M; El Husseini M; Harabacz L; Pineker V; Grahl S; Pongratz V; Berthele A; Riederer I; Zimmer C; Hemmer B; Kirschke JS; Mühlau M
Neuroimage Clin; 2022; 34():103006. PubMed ID: 35468568
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.
Bonacchi R; Pagani E; Meani A; Cacciaguerra L; Preziosa P; De Meo E; Filippi M; Rocca MA
Radiology; 2020 Sep; 296(3):605-615. PubMed ID: 32573387
[TBL] [Abstract][Full Text] [Related]
7. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
[TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
10. Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis.
Ciccarelli O; Barkhof F; Calabrese M; De Stefano N; Eshaghi A; Filippi M; Gasperini C; Granziera C; Kappos L; Rocca MA; Rovira À; Sastre-Garriga J; Sormani MP; Tur C; Toosy AT;
Neurology; 2024 Jul; 103(1):e209444. PubMed ID: 38889384
[TBL] [Abstract][Full Text] [Related]
11. Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy.
Ladopoulos T; Matusche B; Bellenberg B; Heuser F; Gold R; Lukas C; Schneider R
Neuroimage Clin; 2022; 36():103166. PubMed ID: 36081258
[TBL] [Abstract][Full Text] [Related]
12. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
13. Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years.
Reeves JA; Mohebbi M; Wicks T; Salman F; Bartnik A; Jakimovski D; Bergsland N; Schweser F; Weinstock-Guttman B; Dwyer MG; Zivadinov R
Mult Scler; 2024 Apr; 30(4-5):535-545. PubMed ID: 38366920
[TBL] [Abstract][Full Text] [Related]
14. Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
Lukas C; Knol DL; Sombekke MH; Bellenberg B; Hahn HK; Popescu V; Weier K; Radue EW; Gass A; Kappos L; Naegelin Y; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):410-8. PubMed ID: 24973341
[TBL] [Abstract][Full Text] [Related]
15. Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis.
Borrelli S; Martire MS; Stölting A; Vanden Bulcke C; Pedrini E; Guisset F; Bugli C; Yildiz H; Pothen L; Elands S; Martinelli V; Smith B; Jacobson S; Du Pasquier RA; Van Pesch V; Filippi M; Reich DS; Absinta M; Maggi P
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200253. PubMed ID: 38788180
[TBL] [Abstract][Full Text] [Related]
16. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
[TBL] [Abstract][Full Text] [Related]
17. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
[TBL] [Abstract][Full Text] [Related]
18. Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis.
Tur C; Carbonell-Mirabent P; Cobo-Calvo Á; Otero-Romero S; Arrambide G; Midaglia L; Castilló J; Vidal-Jordana Á; Rodríguez-Acevedo B; Zabalza A; Galán I; Nos C; Salerno A; Auger C; Pareto D; Comabella M; Río J; Sastre-Garriga J; Rovira À; Tintoré M; Montalban X
JAMA Neurol; 2023 Feb; 80(2):151-160. PubMed ID: 36534392
[TBL] [Abstract][Full Text] [Related]
19. Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
Portaccio E; Betti M; De Meo E; Addazio I; Pastò L; Razzolini L; Totaro R; Spitaleri D; Lugaresi A; Cocco E; Onofrj M; Di Palma F; Patti F; Maimone D; Valentino P; Torri Clerici V; Protti A; Ferraro D; Lus G; Maniscalco GT; Brescia Morra V; Salemi G; Granella F; Pesci I; Bergamaschi R; Aguglia U; Vianello M; Simone M; Lepore V; Iaffaldano P; Comi G; Filippi M; Trojano M; Amato MP;
J Neurol; 2024 May; ():. PubMed ID: 38805052
[TBL] [Abstract][Full Text] [Related]
20. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
